Microbiota: a key orchestrator of cancer therapy

S Roy, G Trinchieri - Nature Reviews Cancer, 2017 - nature.com
The microbiota is composed of commensal bacteria and other microorganisms that live on
the epithelial barriers of the host. The commensal microbiota is important for the health and …

Cisplatin mouse models: treatment, toxicity and translatability

M Perše - Biomedicines, 2021 - mdpi.com
Cisplatin is one of the most widely used chemotherapeutic drugs in the treatment of a wide
range of pediatric and adult malignances. However, it has various side effects which limit its …

Cisplatin‐induced rodent model of kidney injury: characteristics and challenges

M Perše, Ž Večerić-Haler - BioMed research international, 2018 - Wiley Online Library
Cisplatin is an antitumor drug used in the treatment of a wide variety of malignancies.
However, its primary dose‐limiting side effect is kidney injury, which is a major clinical …

ROS-modulated therapeutic approaches in cancer treatment

MH Raza, S Siraj, A Arshad, U Waheed… - Journal of cancer …, 2017 - Springer
Purpose Reactive oxygen species (ROS) are produced in cancer cells as a result of
increased metabolic rate, dysfunction of mitochondria, elevated cell signaling, expression of …

Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications

C Guo, G Dong, X Liang, Z Dong - Nature Reviews Nephrology, 2019 - nature.com
Acute kidney injury (AKI) is a major public health concern associated with high morbidity and
mortality. Despite decades of research, the pathogenesis of AKI remains incompletely …

PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury

Y Wang, C Tang, J Cai, G Chen, D Zhang… - Cell death & …, 2018 - nature.com
Cisplatin is a widely used chemotherapeutic drug with notorious toxicity in the kidneys,
which involves mitochondrial dysfunction and damage in renal tubular cells. Mitophagy is a …

Microbes and cancer

A Dzutsev, JH Badger, E Perez-Chanona… - Annual review of …, 2017 - annualreviews.org
Commensal microorganisms (the microbiota) live on all the surface barriers of our body and
are particularly abundant and diverse in the distal gut. The microbiota and its larger host …

The predictive role of the biomarker kidney molecule-1 (KIM-1) in acute kidney injury (AKI) cisplatin-induced nephrotoxicity

DM Tanase, EM Gosav, S Radu, CF Costea… - International journal of …, 2019 - mdpi.com
Acute kidney injury (AKI) following platinum-based chemotherapeutics is a frequently
reported serious side-effect. However, there are no approved biomarkers that can properly …

Sirt3 modulates fatty acid oxidation and attenuates cisplatin‐induced AKI in mice

M Li, C Li, Z Ye, J Huang, Y Li, W Lai… - Journal of cellular …, 2020 - Wiley Online Library
Fatty acid oxidation (FAO) dysfunction is one of the important mechanisms of renal fibrosis.
Sirtuin 3 (Sirt3) has been confirmed to alleviate acute kidney injury (AKI) by improving …

Non-coding RNAs in kidney injury and repair

Z Liu, Y Wang, S Shu, J Cai… - American Journal of …, 2019 - journals.physiology.org
Acute kidney injury (AKI) is a major kidney disease featured by a rapid decline of renal
function. Pathologically, AKI is characterized by tubular epithelial cell injury and death …